Hsinchu, Taiwan

Abiral Regmi

This inventor holds 1 USPTO granted patent. Top assignee: National Tsing Hua University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abiral Regmi. Retrieved from https://idiyas.com/inventor/abiral-regmi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Abiral Regmi in Cardiovascular Disease Detection

Introduction

Abiral Regmi is an innovative inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the detection of cardiovascular diseases. His work focuses on developing methods that enhance the accuracy and efficiency of disease biomarker analysis.

Latest Patents

Abiral Regmi holds a patent for a method designed to detect cardiovascular disease biomarkers. This method involves analyzing the concentration of a cardiovascular disease (CVD) biomarker in a liquid sample. The process includes applying the liquid sample to a biosensor, which consists of a transistor with specific terminals and a reactive electrode. The electrode is equipped with a receptor that binds specifically to the CVD biomarker. The method further involves applying a voltage pulse and monitoring the response current to analyze the biomarker concentration effectively.

Career Highlights

Abiral Regmi is affiliated with Tsinghua University, where he continues to advance his research in biomedical applications. His work has garnered attention for its potential impact on early detection and diagnosis of cardiovascular diseases.

Collaborations

Abiral has collaborated with notable colleagues, including Yu-Lin Wang and Gwo-Bin Lee, who share his commitment to innovation in health technology.

Conclusion

Abiral Regmi's contributions to the detection of cardiovascular disease biomarkers represent a significant advancement in medical technology. His innovative methods have the potential to improve diagnostic processes and patient outcomes in the field of cardiovascular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…